Pulmonary Neuroendocrine Tumor

• CLINICAL_TRIALS research · 2026-04-22
  Clinical Trial Update: Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors [Phase 2]

  This clinical trial update describes a Phase 2 study evaluating Lutetium-177 dotatate in somatostatin receptor-positive advanced pulmonary n…

• CLINICAL_TRIALS research · 2026-01-22
  Clinical Trial Update: Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors [Phase 2]

  A Phase 2 clinical trial comparing Surufatinib plus chemotherapy versus Surufatinib alone in patients with pulmonary neuroendocrine tumors i…

• CLINICAL_TRIALS research · 2025-01-08
  Clinical Trial Update: Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors [Phase 2]

  Phase II study evaluating Adebrelimab plus chemotherapy and Apatinib for advanced pulmonary neuroendocrine tumors; trial status is not yet r…

• CLINICAL_TRIALS research · 2024-07-16
  Clinical Trial Update: Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors [Phase 2]

  A Phase 2 clinical trial is evaluating nab-sirolimus in patients with well-differentiated neuroendocrine tumors of the gastrointestinal trac…

• CLINICAL_TRIALS research · 2024-05-07
  Clinical Trial Update: Observational Study on GEP-and Pulm-NET Treated at FPG

  An observational clinical trial update describes a study of gastroenteropancreatic and pulmonary neuroendocrine tumors treated at Fondazione…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.